Theseus Pharmaceuticals Market Cap

Quadient has a market cap or net worth of 468.06 million as of August 1, 2025. Its market cap has decreased by -12.78% in one year.

Market Cap

468.06M

Enterprise Value

1.12B

Revenue

913.63M

Ranking

n/a

PE Ratio

8.44

Stock Price

$15.92

Market Cap Chart

Since June 11, 1999, Quadient's market cap has increased from 410.27M to 468.06M, an increase of 14.09%. That is a compound annual growth rate of 0.51%.

Market Cap History

Date	Market Cap	% Change
Aug 1, 2025	468.06M	-10.58%
Dec 31, 2024	523.44M	-8.67%
Dec 29, 2023	573.11M	36.50%
Dec 30, 2022	419.85M	-23.94%
Dec 31, 2021	552.00M	13.99%
Dec 31, 2020	484.27M	-23.03%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	178.30B
HSBC Holdings	160.62B
Shell	157.43B
Unilever	111.06B
British American Tobacco p.l.c.	87.18B
Rolls-Royce Holdings	82.38B
Rio Tinto Group	78.40B
RELX PLC	71.47B

Market Cap Rankings